Stockreport

CytRx Comments on Quarterly Results and Year-to-Date Progress

Orphazyme A/S - American Depositary Shares  (ORPH) 
PDF Continues Focusing on Near-Term Revenue Opportunities Linked to Orphazyme’s Potential Regulatory Approvals for Arimoclomol in the Treatment of Niemann-Pick Disease Type [Read more]